Novocure Receives FDA Approval for Second Generation Optune System

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. NAVN
4. HUMA
5. USO
6. CHWY
7. SPCX
8. cASY
9. TSLA
10. HUM

Go back to Novocure Receives FDA Approval for Second Generation Optune System
(NASDAQ: NVCR) Delayed: 16.65 --0 (-0%)
Previous Close $16.65    52 Week High $28.95 
Open $16.65    52 Week Low $5.95 
Day High $16.65    P/E N/A 
Day Low $16.65    EPS $0.00 
Volume 5,035